A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
The global Travelers Vaccines market was valued at US$ 3091.3 million in 2020 and is expected to reach US$ 5578.8 million by the end of 2029, growing at a CAGR of 8.8% during 2021-2029.
This report focuses on Travelers Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Travelers Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Travelers Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Segment by End Users
Tourists
Students
Workers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
1 Travelers Vaccines Market Overview
1.1 Product Overview and Scope of Travelers Vaccines
1.2 Travelers Vaccines Segment by Type
1.2.1 Global Travelers Vaccines Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Travelers Vaccines Segment by End Users
1.3.1 Global Travelers Vaccines Sales Comparison by End Users: (2021-2029)
1.3.2 Tourists
1.3.3 Students
1.3.4 Workers
1.3.5 Others
1.4 Global Travelers Vaccines Market Size Estimates and Forecasts
1.4.1 Global Travelers Vaccines Revenue 2016-2029
1.4.2 Global Travelers Vaccines Sales 2016-2029
1.4.3 Travelers Vaccines Market Size by Region: 2016 Versus 2021 Versus 2029
2 Travelers Vaccines Market Competition by Manufacturers
2.1 Global Travelers Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Travelers Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Travelers Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Travelers Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Travelers Vaccines Market Competitive Situation and Trends
2.5.1 Travelers Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Travelers Vaccines Players Market Share by Revenue
2.5.3 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Travelers Vaccines Retrospective Market Scenario by Region
3.1 Global Travelers Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Travelers Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Travelers Vaccines Market Facts & Figures by Country
3.3.1 North America Travelers Vaccines Sales by Country
3.3.2 North America Travelers Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Travelers Vaccines Market Facts & Figures by Country
3.4.1 Europe Travelers Vaccines Sales by Country
3.4.2 Europe Travelers Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Travelers Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Travelers Vaccines Sales by Region
3.5.2 Asia Pacific Travelers Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Travelers Vaccines Market Facts & Figures by Country
3.6.1 Latin America Travelers Vaccines Sales by Country
3.6.2 Latin America Travelers Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Travelers Vaccines Sales by Country
3.7.2 Middle East and Africa Travelers Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Travelers Vaccines Historic Market Analysis by Type
4.1 Global Travelers Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Travelers Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Travelers Vaccines Price by Type (2016-2021)
5 Global Travelers Vaccines Historic Market Analysis by End Users
5.1 Global Travelers Vaccines Sales Market Share by End Users (2016-2021)
5.2 Global Travelers Vaccines Revenue Market Share by End Users (2016-2021)
5.3 Global Travelers Vaccines Price by End Users (2016-2021)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Travelers Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Travelers Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Corporation Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 CNBG Travelers Vaccines Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Sanofi Pasteur MSD
6.6.1 Sanofi Pasteur MSD Corporation Information
6.6.2 Sanofi Pasteur MSD Description and Business Overview
6.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
6.6.5 Sanofi Pasteur MSD Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Serum Institute of India Travelers Vaccines Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Biokangtai
6.8.1 Biokangtai Corporation Information
6.8.2 Biokangtai Description and Business Overview
6.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biokangtai Travelers Vaccines Product Portfolio
6.8.5 Biokangtai Recent Developments/Updates
7 Travelers Vaccines Manufacturing Cost Analysis
7.1 Travelers Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Travelers Vaccines
7.4 Travelers Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Travelers Vaccines Distributors List
8.3 Travelers Vaccines Customers
9 Travelers Vaccines Market Dynamics
9.1 Travelers Vaccines Industry Trends
9.2 Travelers Vaccines Growth Drivers
9.3 Travelers Vaccines Market Challenges
9.4 Travelers Vaccines Market Restraints
10 Global Market Forecast
10.1 Travelers Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Travelers Vaccines by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Travelers Vaccines by Type (2022-2029)
10.2 Travelers Vaccines Market Estimates and Projections by End Users
10.2.1 Global Forecasted Sales of Travelers Vaccines by End Users (2022-2029)
10.2.2 Global Forecasted Revenue of Travelers Vaccines by End Users (2022-2029)
10.3 Travelers Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Travelers Vaccines by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Travelers Vaccines by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Travelers Vaccines Sales (K Doses) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Travelers Vaccines Sales (K Doses) Comparison by End Users (2021-2029)
Table 3. Global Travelers Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Travelers Vaccines Covered in This Study
Table 5. Global Travelers Vaccines Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Travelers Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Travelers Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Travelers Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Travelers Vaccines Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Travelers Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Travelers Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Travelers Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Travelers Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Travelers Vaccines Sales by Region (2016-2021) & (K Doses)
Table 16. Global Travelers Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Travelers Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Travelers Vaccines Sales by Country (2016-2021) & (K Doses)
Table 19. North America Travelers Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Travelers Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Travelers Vaccines Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Travelers Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Travelers Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Travelers Vaccines Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Travelers Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Travelers Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Travelers Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Travelers Vaccines Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Travelers Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Travelers Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Travelers Vaccines Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Travelers Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Travelers Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Travelers Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Travelers Vaccines Sales (K Doses) by Type (2016-2021)
Table 39. Global Travelers Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Travelers Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Travelers Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Travelers Vaccines Price (USD/Dose) by Type (2016-2021)
Table 43. Global Travelers Vaccines Sales (K Doses) by End Users (2016-2021)
Table 44. Global Travelers Vaccines Sales Market Share by End Users (2016-2021)
Table 45. Global Travelers Vaccines Revenue (Million US$) by End Users (2016-2021)
Table 46. Global Travelers Vaccines Revenue Share by End Users (2016-2021)
Table 47. Global Travelers Vaccines Price (USD/Dose) by End Users (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Travelers Vaccines Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Sanofi Pasteur Corporation Information
Table 54. Sanofi Pasteur Description and Business Overview
Table 55. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Sanofi Pasteur Travelers Vaccines Product
Table 57. Sanofi Pasteur Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Merck Travelers Vaccines Product
Table 62. Merck Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Pfizer Travelers Vaccines Product
Table 67. Pfizer Recent Developments/Updates
Table 68. CNBG Corporation Information
Table 69. CNBG Description and Business Overview
Table 70. CNBG Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. CNBG Travelers Vaccines Product
Table 72. CNBG Recent Developments/Updates
Table 73. Sanofi Pasteur MSD Corporation Information
Table 74. Sanofi Pasteur MSD Description and Business Overview
Table 75. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Sanofi Pasteur MSD Travelers Vaccines Product
Table 77. Sanofi Pasteur MSD Recent Developments/Updates
Table 78. Serum Institute of India Corporation Information
Table 79. Serum Institute of India Description and Business Overview
Table 80. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Serum Institute of India Travelers Vaccines Product
Table 82. Serum Institute of India Recent Developments/Updates
Table 83. Biokangtai Corporation Information
Table 84. Biokangtai Description and Business Overview
Table 85. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Biokangtai Travelers Vaccines Product
Table 87. Biokangtai Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Travelers Vaccines Distributors List
Table 91. Travelers Vaccines Customers List
Table 92. Travelers Vaccines Market Trends
Table 93. Travelers Vaccines Growth Drivers
Table 94. Travelers Vaccines Market Challenges
Table 95. Travelers Vaccines Market Restraints
Table 96. Global Travelers Vaccines Sales Forecast by Type (2022-2029) & (K Doses)
Table 97. Global Travelers Vaccines Sales Market Share Forecast by Type (2022-2029)
Table 98. Global Travelers Vaccines Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 99. Global Travelers Vaccines Revenue Market Share Forecast by Type (2022-2029)
Table 100. Global Travelers Vaccines Sales Forecast by End Users (2022-2029) & (K Doses)
Table 101. Global Travelers Vaccines Sales Market Share Forecast by End Users (2022-2029)
Table 102. Global Travelers Vaccines Revenue Forecast by End Users (2022-2029) & (US$ Million)
Table 103. Global Travelers Vaccines Revenue Market Share Forecast by End Users (2022-2029)
Table 104. Global Travelers Vaccines Sales Forecast by Region (2022-2029) & (K Doses)
Table 105. Global Travelers Vaccines Sales Market Share Forecast by Region (2022-2029)
Table 106. Global Travelers Vaccines Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 107. Global Travelers Vaccines Revenue Market Share Forecast by Region (2022-2029)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Travelers Vaccines
Figure 2. Global Travelers Vaccines Market Share by Type in 2020 & 2029
Figure 3. Meningococcal Vaccine Product Picture
Figure 4. Japanese Encephalitis Vaccine Product Picture
Figure 5. Yellow Fever Vaccine Product Picture
Figure 6. Hepatitis Vaccine Product Picture
Figure 7. Cholera Vaccine Product Picture
Figure 8. Other Product Picture
Figure 9. Global Travelers Vaccines Market Share by End Users in 2020 & 2029
Figure 10. Tourists
Figure 11. Students
Figure 12. Workers
Figure 13. Others
Figure 14. Global Travelers Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 15. Global Travelers Vaccines Market Size 2016-2029 (US$ Million)
Figure 16. Global Travelers Vaccines Sales 2016-2029 (K Doses)
Figure 17. Global Travelers Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 18. Travelers Vaccines Sales Share by Manufacturers in 2020
Figure 19. Global Travelers Vaccines Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Travelers Vaccines Players: Market Share by Revenue in 2020
Figure 21. Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Travelers Vaccines Sales Market Share by Region (2016-2021)
Figure 23. Global Travelers Vaccines Sales Market Share by Region in 2020
Figure 24. Global Travelers Vaccines Revenue Market Share by Region (2016-2021)
Figure 25. Global Travelers Vaccines Revenue Market Share by Region in 2020
Figure 26. U.S. Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Travelers Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Travelers Vaccines by Type (2016-2021)
Figure 51. Sales Market Share of Travelers Vaccines by End Users (2016-2021)
Figure 52. Sales Market Share of Travelers Vaccines by End Users in 2020
Figure 53. Revenue Share of Travelers Vaccines by End Users (2016-2021)
Figure 54. Revenue Share of Travelers Vaccines by End Users in 2020
Figure 55. Manufacturing Cost Structure of Travelers Vaccines
Figure 56. Manufacturing Process Analysis of Travelers Vaccines
Figure 57. Travelers Vaccines Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
